The Use of Hyperbaric Oxygen Therapy in Secondary Rhinoplasty
Facial Plastic Surgery Clinics of North America · 2026-05 · 34 (2) · 177-206
DOI: 10.1016/j.fsc.2026.01.015 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Facial Plastic Surgery Clinics of North America, 2026-05. Verfasst von Dean M Toriumi. Beteiligte Einrichtung: Department of Otolaryngology Head & Neck Surgery, Rush University Medical School and Toriumi Facial Plastics, Chicago, IL, USA; Private Practice, Chi…. Hauptthemen laut MEDLINE: Rhinoplasty, Hyperbaric Oxygenation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Hyperbaric oxygen therapy (HBOT) has proven to be very helpful to rhinoplasty healing, particularly in complex rhinoplasty defects involving compromised vascularity, the use of flaps or composite grafts, and in cases with prior infection. Outcomes can be maximized when HBOT is combined with nanofat and the Silastic healing chamber. Safety and comfort are critical in the application of HBOT in rhinoplasty.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology Head & Neck Surgery, Rush University Medical School and Toriumi Facial Plastics, Chicago, IL, USA; Private Practice, Chicago, IL, USA. Electronic address: deantoriumi@toriumimd.com.
Zitieren
APA
Toriumi, D. M. (2026). The Use of Hyperbaric Oxygen Therapy in Secondary Rhinoplasty. Facial Plastic Surgery Clinics of North America, 34(2), 177-206. https://doi.org/10.1016/j.fsc.2026.01.015
Vancouver
Toriumi DM. The Use of Hyperbaric Oxygen Therapy in Secondary Rhinoplasty. Facial Plastic Surgery Clinics of North America. 2026;34(2):177-206. doi:10.1016/j.fsc.2026.01.015
BibTeX
@article{Toriumi2026,
author = {Toriumi, Dean M},
title = {The Use of Hyperbaric Oxygen Therapy in Secondary Rhinoplasty},
journal = {Facial Plastic Surgery Clinics of North America},
year = {2026},
volume = {34},
number = {2},
pages = {177--206},
doi = {10.1016/j.fsc.2026.01.015}
}
EUVIMED